IMR Press / CEOG / Volume 8 / Issue 3 / pii/1634266120946-1776972274

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Preliminary evaluation of a new protocol for the actino-therapeutical treatment of uterine cervix carcinoma in stages Ⅱ and Ⅲ
Show Less
1 2nd Chair of Obstetric and Gynecological Clinic
2 Institute of Radiology, University of Genoa (Italy)
Clin. Exp. Obstet. Gynecol. 1981, 8(3), 89–92;
Published: 10 September 1981
Abstract

This study concerns 89 patients affected by uterine cervicocarcinoma at stage II or III, hospitalized at the Obstetric and Gynecological Clinic of Genoa University and subjected to transcutaneous (cobalt) and intracavitary (cesium137) actinotherapy. One year after the treatment end, the Authors observed and compared post-actinic troubles in a group of patients who had undergone a classic actinic treatment and in those subjected to a new therapeutical protocol based on dose fractionation. The latter showed a higher incidence of immediate troubles, but a lower percentage of cerviconeoplasia persistence.
Share
Back to top